Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 4;33(2):151.
doi: 10.1007/s00520-025-09212-3.

The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviews

Affiliations

The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviews

Darren Haywood et al. Support Care Cancer. .

Abstract

Purpose: A significant number of cancer survivors experience cancer-related cognitive impairment (CRCI), which can impact their ability to think, reason, make decisions, and perform daily actions. In recent years, non-pharmacological interventions for CRCI have gained significant attention. These interventions include exercise, cognitive behavioural therapy, cognitive training/remediation, dietary, mind-body, and multi-modal/complex interventions. This umbrella review provides a critical overview to inform guidelines and current practice, identify the most promising interventions, and uncover gaps in the research literature.

Methods: This umbrella review of systematic reviews was pre-registered on Open Science Framework and PROSPERO. Six databases were searched. Systematic reviews (SR) assessing any non-pharmacological interventions to improve cognition in cancer (any type) were included. The overview followed gold-standard guidelines and recommendations. The results were narratively synthesised, and descriptive statistics and effect size ranges were calculated.

Results: Sixty-four (n = 64) SRs were included. Results were synthesised into four non-pharmacological domains. Cognitive training/rehabilitation had the strongest evidence for efficacy. Physical activity/exercise showed promising efficacy; however, the variability of findings was considerable. Mind-body and psychological/behavioural therapy interventions were limited, but there was evidence for short-term effectiveness. Multi-modal/complex interventions showed potential for improving cognition in cancer but were poorly defined.

Conclusions: Overall, non-pharmacological interventions demonstrated efficacy for improving cognition in cancer. There were limited intervention characteristics within domains which were consistently related to efficacy. Three key recommendations are provided for future research: (1) adopt harmonisation and reporting guidelines; (2) develop definitional guidelines of cognitive domains for CRCI research; and (3) assess intervention and participant characteristics associated with positive versus null/negative findings.

Keywords: Cancer; Cancer-related cognitive impairment; Cognition; Cognitive rehabilitation; Exercise; Intervention; Non-pharmacological.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: Not Applicable. Consent to participate: Not Applicable. Consent for publication: Not Applicable. Competing interests: This project was completed within a MASCC Cognition Fellowship. NHH is an Associate Editor of the Supportive Care in Cancer journal. DH is a MASCC Cognition Fellow; NHH is Chair of MASCC Fatigue and MASCC Exercise Oncology; NHH is a MASCC Terry Langbaum Survivorship Fellow; AC is the MASCC President-Elect; RJC is MASCC Treasurer; MBL is MASCC Immediate Past President.

Figures

Fig. 1
Fig. 1
PRISMA flow chart

References

    1. Binarelli G et al (2023) Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment. Expert Rev Neurother 23(3):249–268 - PubMed
    1. Mayo SJ et al (2021) Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. Support Care Cancer 29:2821–2840 - PubMed
    1. Haywood D et al (2024) Cancer-related cognitive impairment as a key contributor to psychopathology in cancer survivors: implications for prevention, treatment and supportive care. Support Care Cancer 32(7):1–5 - PMC - PubMed
    1. Haywood D et al (2023) “Is my brain ever going to work fully again?”: challenges and needs of cancer survivors with persistent cancer-related cognitive impairment. Cancers 15(22):5331 - PMC - PubMed
    1. Henderson FME, Cross AJ, Baraniak AR (2019) ‘A new normal with chemobrain’: experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors. Health Psychol Open 6(1):2055102919832234 - PMC - PubMed

Publication types